These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4690398)
21. [Clinical observations on cutaneous cicatrization with F.I. 6321-N (trofodermin)]. Molinari L; Bolognesi L Minerva Chir; 1969 Feb; 24(3):177-87. PubMed ID: 5354075 [No Abstract] [Full Text] [Related]
22. [Comparative evaluation of the treatment of radiation skin injuries with oxycort ointment and Peruvian balsam]. Nikulin AA; Krylova EA Farmakol Toksikol; 1980; 43(1):97-100. PubMed ID: 7379999 [TBL] [Abstract][Full Text] [Related]
23. Management of neuritis in leprosy. Pfaltzgraff RE Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065 [No Abstract] [Full Text] [Related]
24. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy]. Renders A Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964 [No Abstract] [Full Text] [Related]
25. Clinical evaluation of Lamprene (Geigy). A preliminary report. Karuru ER Lepr Rev; 1970 Apr; 41(2):83-8. PubMed ID: 5453083 [No Abstract] [Full Text] [Related]
26. B.663 and erythema nodosum leprosum. Pettit JH Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363 [No Abstract] [Full Text] [Related]
30. An indigenous drug (Sovanj) in the treatment of plantar trophic ulcers in leprosy. Kundu S; Ghosh S Bull Calcutta Sch Trop Med; 1966 Jul; 14(3):96-7. PubMed ID: 5981469 [No Abstract] [Full Text] [Related]
31. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy]. Vischer WA Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384 [No Abstract] [Full Text] [Related]
32. The treatment of erythema nodosum leprosum with B.663. A controlled study. Pettit JH Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017 [No Abstract] [Full Text] [Related]
33. Antivenoms: Life-saving drugs for envenomings by animal bites and stings. Gutiérrez JM Toxicon; 2018 Aug; 150():11-12. PubMed ID: 29746977 [No Abstract] [Full Text] [Related]
34. Clofazimine: current status and future prospects. Cholo MC; Steel HC; Fourie PB; Germishuizen WA; Anderson R J Antimicrob Chemother; 2012 Feb; 67(2):290-8. PubMed ID: 22020137 [TBL] [Abstract][Full Text] [Related]
35. Rifampicin in experimental Mycobacterium ulcerans infection. Stanford JL; Phillips I J Med Microbiol; 1972 Feb; 5(1):39-45. PubMed ID: 5022508 [No Abstract] [Full Text] [Related]
36. Lucio leprosy with lucio phenomenon. Saoji V; Salodkar A Indian J Lepr; 2001; 73(3):267-72. PubMed ID: 11840599 [TBL] [Abstract][Full Text] [Related]
37. A study of skin pigmentation by clofazimine. Levy L; Randall HP Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493 [No Abstract] [Full Text] [Related]
38. [Topical treatment of some dystrophic and inflammatory lesions of the skin and soft tissues]. Palmieri B; Boraldi F Arch Sci Med (Torino); 1977; 134(4):481-5. PubMed ID: 610695 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the action of ointment in 393-S-12 chronic cutaneous ulcers]. Torres V; Massmanian A Rev Clin Esp; 1976 Apr; 141(1):61-5. PubMed ID: 181794 [No Abstract] [Full Text] [Related]
40. Topical application of human leukocyte interferon in stasis ulcers and deep burns. Ikić D; Brnobić A; Lipozencić J; Malecek J; Smerdel S; Delimar N; Soos E Int J Clin Pharmacol Ther Toxicol; 1981 Oct; 19(10):450-2. PubMed ID: 6169671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]